Skip to content
Clinical Research Society

Clinical Research Society

International Society for Clinical Research and Translational Medicine

  • About Us
    • Executive Council
    • Committees
    • President’s Message
    • Code of Ethics
    • Our Logo
  • Membership
    • Professional Membership
    • Associate Membership
    • Student Membership
    • Institutional Membership
    • Membership Renewal
  • Training & Certification
    • GCP Certification
    • CRA Certification
    • CRC Certification
    • Emerging Clinical Research Professional
    • Project Management Certification
    • Training Demo
    • Register for Certification Exam
  • Careers
  • Contact

pfizer

Clinical Research / Pharma News 

FDA Approved to Remove Black Box Warning on Pfizer’s Chantix

anti-smoking drug, Black Box Warning, pfizer

U.S. Food and Drug Administration on 16th December permitted Pfizer to take out a serious warning from the label of

Read more
Clinical Research / Pharma News 

Pfizer’s Ibrance Clears Initial Barrier for UK’s Early Access Scheme

Breast Cancer drug, Early Access Scheme, MHRA, pfizer

Pfizer’s new cancer drug Ibrance has cleared the initial barrier to joining the UK’s Early Access to Medicines Scheme after

Read more
Clinical Research / Pharma News 

Pfizer’s Investigational Breast Cancer Drug Shows Promising Outcomes in Early Clinical Trial

drugs for breast cancer, palbociclib, pfizer, Treatment for breast cancer

The world’s second biggest pharmaceutical company Pfizer states that an investigational drug has displayed motivating outcomes in treating advanced breast

Read more
Clinical Research and Pharma News 

Pfizer succeeds in the offer for Icagen in a third attempt

0 Comments pfizer

Giant drug developer Pfizer announced that it has succeeded in its tender offer for shares for Icagen after two extensions.

Read more
Clinical Research and Pharma News 

Icagen stock tender offer extended by Pfizer

0 Comments pfizer

Since the numbers of shares tendered by Icagen on Thursday did not meet Pfizer Inc.’s requirement, the giant drug developer

Read more
Clinical Research and Pharma News 

Pfizer’s Virginia facility acquired by Fareva

0 Comments pfizer

In a news release, Gov. Bob McDonnell announced that Fareva will purchase Pfizer’s manufacturing plant in Henrico County and will

Read more
Clinical Research and Pharma News 

Pfizer refuses to budge from $6 Per Share Offer for Icagen

0 Comments pfizer

Earlier on Friday, Pfizer notified Icagen’s board that its final buy out offer for Icagen would be priced at $6

Read more
Clinical Research and Pharma News 

Gene-targeting lung cancer drug received FDA approval

0 Comments lung cancer, nsclc, oncology, pfizer, xalkori

The Food and Drug Administration announced that it has approved Pfizer’s new drug for treating non-small-cell lung cancer patients with

Read more
Clinical Research and Pharma News 

EU to commence review of 2 cancer drugs by Pfizer

0 Comments pfizer

Earlier on Wednesday, Pfizer Inc. announced that the European Union regulators are reviewing the applications filed by the giant drugmaker

Read more
Clinical Research and Pharma News 

Pfizer prevails in Viagra Patent Trial

0 Comments pfizer, teva, viagra

Earlier today, the world’s largest drugmaker Pfizer declared that it triumphed in the lawsuit against generic drugmaker Teva Pharmaceuticals USA

Read more
  • ← Previous

Example Widget

This is an example widget to show how the Right Sidebar looks by default. You can add custom widgets from the widgets screen in the admin. If custom widgets are added then this will be replaced by those widgets.

Copyright © 2023 Clinical Research Society. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.

Offer the visitors your services or goods.

Describe what they will receive and how they will benefit from it.

Do not forget a coaxing call to action, but also a way to decline.
Put the final call to action.

  • Yes I want it!
  • No thank you!